Bayer (BAYRY) announced positive topline results from the global Phase III study OCEANIC-STROKE, with its investigational, once daily, oral FXIa ...

Markets expected to open flat amid increased volatility ahead of F&O settlement, with global sentiment influencing movements.

Asundexian has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) as a potential treatment for stroke prevention in patients after a non-cardioembolic ischemic stroke.

The Bloomberg U.S. Aggregate Bond Index, the fund’s benchmark, returned 2.03% in the third quarter, boosting its year-to-date ...

The showdown over Congressional maps in Texas has landed before the U.S. Supreme Court.

The Voya Target Retirement Fund's primary performance objective is to outperform its strategic allocation composite benchmark ...

The state Elections Commission has gone off the rails. Lawmakers and others have some ideas for fixing it but it won't be ...

City Council Member Chi Ossé’s planned primary challenge to House Minority Leader Hakeem Jeffries is now on life support.

A study of U.S. mothers finds that elevated cortisol late in pregnancy is tied to earlier tooth eruption in infants.

The penalty for excessive plank wear erases crucial points from Norris' championship lead with two grands prix remaining ...

SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing ...

Topline results from the phase 3 HERIZON-GEA-01 trial show that the HER2-targeted bispecific antibody zanidatamab-hrii ...